| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f600d1296c13d2e86af0e53efe367729 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70589
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08 |
| filingDate |
2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29a8aaa59e721bfceed1914753cf94fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_509d42e4905f17231c1e61b6e39314fb |
| publicationDate |
2003-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1339745-A1 |
| titleOfInvention |
Immunotherapeutic methods and molecules |
| abstract |
A peptide comprising an HLA-binding peptide of human CD45 polypeptide or a portion or variant of said peptide provided that the peptide is nothe intact human CD45 polypeptide. Preferably, the peptide comprises the amino acid sequence FLYDVIAST or ALIAFLAFL or KLFTAKLNV or MIWEQKATV or NLSELHPYL or VNLSELHPYL or LLAFGAFAFL or YLYNKETKL or LILDVPPGV or TLILDVPPGB or ILYNNHKFT or ILPYDYNRV or YILIHQALV or FQLHDCTQV or KLLAFGFAFL or YQYQYTNWSV or a portion or variant of any of these. Methods of leukaemia immunotherpay using specific cytotoxic T lymphocytes are also disclosed. |
| priorityDate |
2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |